“…NSPs regulate inflammatory processes via several means, including proteolytic truncation of chemokines, cytokines, and growth factors to modulate their activity, activation or shedding of cell-surface receptors at the sites of inflammation, and controlling pathways of apoptosis ( Pham, 2008 ; Hahn et al, 2019 ). The recent research findings illustrate that CatG systematically degrades fibroblast growth factor-1 (FGF-1), IL-3, IL-6, IL-7, IL-15, IL-18, IL-31, and IL-33, stem cell factor (SCF), whereas NE and PR3 completely cleave cytokine ciliary neurotrophic factor (CNTF), connective tissue growth factor (CTGF), FGF-1, FGF-9, FGF-19, FMS-like tyrosine kinase 3 ligand (flt3L), granulocyte colony-stimulating factor (G-CSF), insulin-like growth factor-1 (IGF-1), IGF-2, IL-3, IL-7, IL-15, IL-16, IL-17A, IL-31, IL-33, neuregulin-1b, SCF, thymic stromal lymphopoietin (TSLP), but not IL-1-α, IL-5, IL-8, monocyte chemoattractant protein-1 (MCP-1), macrophage colony-stimulating factor (M-CSF), RANTES, TNF-α, which are resistant to proteolysis, proposing that NSPs selectively preserve a specific set of cytokines and chemokines necessary for recruitment of inflammatory cells to the sites of tissue damage or infection ( Fu et al, 2017 ; Fu et al, 2020 ). Furthermore, PR3 can promote apoptosis in aging neutrophils via an activating cleavage of procaspase-3 in the cytosol of neutrophils.…”